Future Science Group
Supplementary Table 2.docx (13.32 kB)

Supplementary Table 2: Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk.docx

Download (13.32 kB)
posted on 2021-12-15, 08:42 authored by Stanislav Kononov, Galina Mal, Iuliia Azarova, Elena Klyosova, Marina Bykanova, Mikhail Churnosov, Alexey Polonikov

Supplementary Table 2. Call rate for genotyped SNPs and number of cases, included into analyses of associations with total cholesterol and low-density lipoprotein cholesterol change, baseline carotid intima-media thickness, and its change during rosuvastatin therapy.